The aim of this study was to investigate the effects of treatment with Cetuximab in three FOSCC cell lines using a human OSCC cell line as a control, by evaluating inhibition of EGFR pathway, impairment of cell proliferation and cell viability, in order to obtain a preliminary assessment of its potential as a possible future candidate for the treatment of this tumor. Here, EGFR is linked to neoplasm.